The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9145593 B1

PDF
Full Text
Expired
Date of Patent:
Sep. 29, 2015

Filed:

Sep. 17, 2012
Applicants:

Jason Trama, Burlington, NJ (US);

Martin E Adelson, East Windsor, NJ (US);

Eli Mordechai, Robbinsville, NJ (US);

Inventors:

Jason Trama, Burlington, NJ (US);

Martin E Adelson, East Windsor, NJ (US);

Eli Mordechai, Robbinsville, NJ (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6895 (2013.01); C12Q 1/689 (2013.01); C12Q 2561/113 (2013.01); C12Q 2565/301 (2013.01); C12Q 2600/156 (2013.01);
Abstract

Methods for using oligonucleotides in the detection ofare disclosed. The oligonucleotides of the invention have nucleotide sequences derived from the gene encoding the cytochrome P450 14 alpha-sterol demethylase (the cyp51A protein) of. The oligonucleotides include primers capable of producing amplicons specific to cyp51A in polymerase chain reactions using nucleic acids isolated fromas templates. The oligonucleotides also include probes capable of detecting these cyp51A-specific amplicons. The oligonucleotides of the invention also include primers for nucleotide sequencing reactions to determine whether an isolate ofis more tolerant than wild-typeto a triazole.


Find Patent Forward Citations

Loading…